Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,126–5,150 of 7,816 matching trials · page 206 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Mild Cognitive Impairment in Men Following Androgen Deprivation NCT01691976 Oestrogen Patches; LHRHa Runs in: United Kingdom · 1 site |
NA other |
WITHDRAWN | 0 | Imperial College London OTHER |
2020-11-20 |
|
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type NCT01922258 Brexpiprazole, OPC-34712 Runs in: Bulgaria; Canada; Finland; France; Russia; Slovenia; Ukra... · 70 sites |
PHASE3 other |
COMPLETED | 270 | Otsuka Pharmaceutical Development & Commercialization, Inc. INDUSTRY |
2020-11-20 |
|
A Trial of an Online Problem-solving Intervention for Aggression NCT04130360 Problem-solving Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 908 | University of Sheffield OTHER |
2020-11-20 |
|
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease NCT00930059 PF-04447943; Placebo Runs in: Canada; Chile; Czechia; United States · 44 sites |
PHASE2 other |
COMPLETED | 191 | Pfizer INDUSTRY |
2020-11-19 |
|
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease NCT00988598 PF-04447943; Placebo Runs in: United States · 3 sites |
PHASE1 symptomatic-cholinergic |
COMPLETED | 15 | Pfizer INDUSTRY |
2020-11-19 |
|
Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial NCT02978729 Two-way videoconference remote genetic counseling; Telephone remote... |
NA other |
COMPLETED | 613 | University of Pennsylvania OTHER |
2020-11-19 |
|
Return of Amyloid Imaging Results (RAISR Study) NCT03121118 Scan Opportunity |
NA other |
COMPLETED | 82 | University of Pittsburgh OTHER |
2020-11-19 |
|
iCST Web-application for People With Dementia NCT03282877 iCST web-application Runs in: United Kingdom · 4 sites |
NA other |
COMPLETED | 43 | University of Nottingham OTHER |
2020-11-19 |
|
Using Implementation Intentions to Reduce Anger and Aggression in Adolescence NCT03693209 Volitional Help Sheet (VHS); Volitional Help Sheet (VHS) Runs in: United Kingdom · 3 sites |
NA other |
COMPLETED | 100 | University of Sheffield OTHER |
2020-11-19 |
|
Goal Management Training for Parkinson Disease Mild Cognitive Impairment NCT04636541 Goal Management Training; Psychoeducation Runs in: Canada · 1 site |
NA other |
COMPLETED | 12 | Laval University OTHER |
2020-11-19 |
|
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease NCT00265148 Rosiglitazone; Placebo Runs in: Canada; United Kingdom; United States · 15 sites |
PHASE2 other |
COMPLETED | 80 | GlaxoSmithKline INDUSTRY |
2020-11-18 |
|
Optimal Dog Visits NCT04635124 Dog visit; Encourage to engage in activity |
NA other |
COMPLETED | 186 | University of Aarhus OTHER |
2020-11-18 |
|
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia NCT00545974 memantine; Placebo pill Runs in: United States · 9 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 81 | University of California, San Francisco OTHER |
2020-11-17 |
|
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) NCT01595646 Saline; Insulin detemir; Insulin Runs in: United States · 2 sites |
PHASE2 other |
COMPLETED | 37 | Wake Forest University Health Sciences OTHER |
2020-11-17 |
|
Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease NCT04118985 Cognitive rehabilitation and health behavior change intervention; S... Runs in: United States · 1 site |
NA other |
COMPLETED | 21 | Mayo Clinic OTHER |
2020-11-17 |
|
Supporting Family Caregivers With Technology for Dementia Home Care NCT02483520 FamTechCare Runs in: United States · 2 sites |
NA other |
COMPLETED | 189 | University of Kansas Medical Center OTHER |
2020-11-13 |
|
Natural History and Patient Journey in Dementia: a Nationwide Linked Electronic Health Records Study of 5.6 Million Individuals. NCT04321486 The study does not have an intervention, but observe the dementia i... |
NA other |
UNKNOWN | 4,309,481 | University College, London OTHER |
2020-11-13 |
|
Cognitive Impairement In Frontotemporal Dementia NCT03452956 None-Observation Only Runs in: United States · 1 site |
NA other |
COMPLETED | 997 | University of Pennsylvania OTHER |
2020-11-12 |
|
Rasagiline Rescue in Alzheimer's Disease Clinical Trial NCT02359552 Rasagiline; Placebo Runs in: United States · 3 sites |
PHASE2 other |
COMPLETED | 50 | The Cleveland Clinic OTHER |
2020-11-10 |
|
Z-Drugs for Sleep Disorders in Alzheimer's Disease NCT03075241 Zolpidem; Zoplicone; Placebo Runs in: Brazil · 1 site |
PHASE3 other |
COMPLETED | 62 | Brasilia University Hospital OTHER |
2020-11-10 |
|
Validation of Cognitive Screenings for the Hearing Impaired NCT03648502 Cognitive tests and hearing tests Runs in: United Kingdom · 2 sites |
NA other |
TERMINATED | 78 | University College, London OTHER |
2020-11-09 |
|
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease. NCT02788513 BI 425809 dose 1; BI 425809 dose 2; BI 425809 dose 3; BI 425809 dos... Runs in: Austria; Canada; Finland; France; Germany; Greece; Hungar... · 95 sites |
PHASE2 other |
COMPLETED | 611 | Boehringer Ingelheim INDUSTRY |
2020-11-06 |
|
The Effect of Cognitive Rehabilitation Therapy in Improving Cognitive Function of Attention Following Mild Traumatic Brain Injury NCT03237676 Structured cognitive rehabilitation therapy; Patient-centred cognit... Runs in: Malaysia · 1 site |
NA other |
COMPLETED | 90 | University of Malaya OTHER |
2020-11-06 |
|
Effects of an Integrative Learning Program on Community Dwelling Old People With Dementia NCT04620083 Integrative Learning Program for Old People with Dementia Runs in: Hong Kong · 1 site |
NA other |
COMPLETED | 37 | Education University of Hong Kong OTHER |
2020-11-06 |
|
Evaluating the Impact of VR-therapy on BPSD and QoL of Individuals With Dementia Admitted to Hospital NCT03941119 VR-therapy Runs in: Canada · 1 site |
NA other |
TERMINATED | 77 | University Health Network, Toronto OTHER |
2020-11-05 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial